Longevity Direct logo in color – promoting personalized longevity insights and AI-driven health optimization
get Started

Basophils (Absolute)

Free Testosterone

DHA (Docosahexaenoic Acid)

Serum Iron

Total Testosterone

Hematocrit

Uric Acid

A/G Ratio (Albumin/Globulin Ratio)

ALT (Alanine Aminotransferase)

RDW (Red Cell Distribution Width)

eGFR (Estimated Glomerular Filtration Rate)

Sed Rate (Erythrocyte Sedimentation Rate)

Homocysteine

LDL Particle Number

MCHC (Mean Corpuscular Hemoglobin Concentration)

Ceruloplasmin

HDL Cholesterol

Hemoglobin

AST (Aspartate Aminotransferase)

DHEA-S (Dehydroepiandrosterone Sulfate)

MCH (Mean Corpuscular Hemoglobin)

Copper Serum

LDH (Lactate Dehydrogenase)

RBC (Red Blood Cell Count)

Albumin

Creatinine

VLDL Cholesterol (calculated)

Immature Granulocytes

Apolipoprotein A1

RBC Magnesium

LDL Particle Size

Triglycerides

Phosphorous

Lipoprotein(a) [Lp(a)]

Bilirubin (Total and Direct)

Cystatin C

WBC (White Blood Cell Count)

Total Cholesterol

Total Protein

Calcium
ALP is a biomarker commonly used for assessing longevity. Maintaining optimal levels of this enzyme can be a key indicator of overall health and longevity.

Alkaline Phosphatase (ALP)

Alkaline Phosphatase (ALP) is a biomarker that is often used in longevity studies to assess overall health and potential lifespan. ALP levels in the blood can indicate liver or bone health, as well as other metabolic processes. High ALP levels may suggest underlying liver disease or bone disorders, while low levels can be associated with malnutrition or certain genetic conditions. Monitoring ALP as part of a comprehensive biomarker panel can provide valuable insights into an individual’s overall health and potential longevity, helping to identify areas for intervention and personalized health optimization strategies.

Biomarker Explained

Alkaline Phosphatase (ALP) is a crucial biomarker utilized in longevity studies to evaluate an individual’s overall health and potential lifespan. ALP levels in the blood can yield valuable information regarding liver and bone health, as well as other metabolic processes. Elevated ALP levels may indicate underlying liver disease or bone disorders, necessitating further investigation and potential intervention. On the other hand, low ALP levels can be associated with malnutrition or certain genetic conditions, highlighting the need for personalized health optimization strategies. Monitoring ALP as part of a comprehensive biomarker panel can offer insightful data on an individual’s overall health and potential longevity, enabling the identification of areas for intervention and the development of personalized health strategies. This underscores the importance of incorporating ALP into longevity studies and personalized health plans to maximize overall well-being and longevity potential.

Keywords:

Alkaline Phosphatase, ALP, Biomarker, Longevity, Liver health, Bone health, Personalized health strategies

Your Longevity Clinic,
from Home.

Longevity Direct is an app within Longr’s Longevity OS, a platform dedicated to extending access to longevity. 

Verify Approval for www.longevity.direct

Home

Rapamycin

Metformin

GLP-1

General Longevity
Heart Health
Weight Management
Glucose Control
Cognitive Function
Diabetes Prevention
Mood Support
Energy & Fatigue
Autoimmune Support
Blood Pressure
Chronic Pain & Arthritis
Aging Skin
Men’s Aging
Women’s Aging

Longevity Library
About

Contact

Client portal

© 2025 Longr Holdings Inc.
1007 North Orange Street | DE 19801 | U.S.A

Prescription products require an online consultation with a physician who will determine if a prescription is appropriate. See product page for important safety information. Benefits outlined on Longevity Direct are based on 3rd party studies.

Note: The above statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. If you are in need of emergency medical attention, please call 911 immediately.

Longevity Direct logo in color – promoting personalized longevity insights and AI-driven health optimization

Rapamycin

Metformin

GLP-1

General Longevity
Heart Health
Weight Management
Glucose Control
Cognitive Function
Diabetes Prevention
Mood Support
Energy & Fatigue
Autoimmune Support
Blood Pressure
Chronic Pain & Arthritis
Aging Skin
Men’s Aging
Women’s Aging

Longevity Library
About

get Started
Client portal

Contact

Questions, suggestions, reflections?

Fill out the form below and a member of our team well get back to you as soon as possible.

FAQS
Contact Form (#14)

How does Rapaymcin work?

Rapamycin slows aging by targeting the mTOR pathway, shifting the body’s focus from growth to repair. It promotes cellular recycling, reduces overgrowth linked to disease, and enhances resilience to stress.

Imagine your body as a city, bustling with activity.

Cells are the workers, and mTOR (mechanistic target of rapamycin) is the city planner, deciding where to focus resources – building new structures, cleaning up waste, or repairing old ones.

As we age, mTOR often prioritizes building (cell growth) over maintenance (cellular repair), leading to “clutter” in our bodies that contributes to aging and disease.

This is where Rapamycin comes in.

It acts like a wise advisor to mTOR, convincing it to slow down unnecessary growth projects and focus on clean up and repair instead.

Specifically, Rapamycin:

Activates cellular recycling (autophagy):

Think of autophagy as the city’s waste management system. Damaged parts of cells are broken down and reused, keeping the system efficient and healthy.

Reduces harmful overgrowth:

Overactive mTOR has been linked to diseases such as cancer, cardiovascular disease, and neurodegenerative conditions like Alzheimer’s. By dialing back excessive growth signals, Rapamycin helps prevent these issues.

Supports stress resilience:

When cells are less focused on growing, they’re better equipped to handle stress, repair damage, and maintain long-term health.